Tracie Oliver - 02 Jul 2024 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Reporting relationship: Chief Commercial Officer
Issuer ticker: ARWR
Reported as of: 02 Jul 2024
Net transaction value: -$237,480
SEC form: 4
Accepted by SEC: 03 Jul 2024, 17:27:36 UTC
Prior SEC filing: 08 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/Tracie Oliver

Key filing fact

Tracie Oliver filed Form 4 for ARROWHEAD PHARMACEUTICALS, INC. (ARWR) on 03 Jul 2024.

Key facts

This page summarizes Tracie Oliver's Form 4 filing for ARROWHEAD PHARMACEUTICALS, INC. (ARWR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jul 2024, 17:27.

Change

Previous filing in this sequence was filed on 08 Jan 2024.
Current net transaction value: -$237,480.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARWR transaction

Common Stock

Sale

Transaction value: $237,480
Shares: -9,394
Change %: -6.9%
Price: $25.28
Shares after: 127,107
Date: 02 Jul 2024
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Footnote F2

Partial disposition of RSUs to satisfy tax withholding obligations.

Footnote F3

Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.